Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Checkpoint+: Improving Access to HIV Prevention and Early Diagnosis Among Migrant Men Who Have Sex With Men, Trans People, and Non-binary People (CHECKPOINT+)

9. november 2026 oppdatert av: Felix Perez Tejera

Checkpoint+ is a community-based observational study designed to better understand barriers to HIV prevention, early diagnosis, and sexual health care among migrant men who have sex with men, trans people, and non-binary people. The study collects information on participants' migration experiences, access to health services, perceived barriers, and suggestions for improving culturally appropriate and accessible HIV and sexual health services.

Based on the proposals made by the community, a set of community-based interventions will be selected and implemented to encourage more migrant MSM, trans and non-binary people to access BCN Checkpoint for the first time for HIV testing and other sexual health services. The interventions will then be evaluated, and the most successful ones will be implemented again to maximise their impact.

Studieoversikt

Detaljert beskrivelse

Checkpoint+ is a community-based research study promoted by Projecte dels NOMS - Hispanosida / BCN Checkpoint. The study focuses on understanding the experiences, needs, and perceived barriers of migrant men who have sex with men, trans people, and non-binary people in relation to HIV prevention, early diagnosis, and broader sexual health care.

The study aims to generate evidence that can help improve access to routine HIV testing, prevention services, and sexual health care for migrant communities. It also seeks to identify participant-informed recommendations for designing more accessible, effective, and culturally appropriate interventions, including awareness campaigns, outreach activities, and service-delivery strategies adapted to the realities of people with diverse migration experiences.

Participation includes an anonymous survey exploring migration history, experiences with health services, perceived barriers to sexual health care, HIV and STI testing, access to information, and proposals for improving services for people with similar backgrounds and needs. Participants may also indicate whether they are willing to be contacted for an optional individual interview, intended to explore personal experiences, opinions, and recommendations in greater depth.

Following the survey and interview phases, the research team, together with the Community Advisory Committee, will select a sample of community-based interventions proposed by participants. These interventions will be implemented with the aim of increasing the number of migrant MSM, trans and non-binary people who access BCN Checkpoint for the first time for HIV testing and other sexual health services. Their impact will be evaluated using aggregated service indicators and information on how first-time users learned about BCN Checkpoint. The most successful interventions will then be implemented again in order to maximise their overall impact and inform future replicability.

The information collected will be analysed in aggregate and anonymised form. Findings may be used to inform community-based HIV prevention and early diagnosis programmes, support the development of more inclusive sexual health services, and contribute to scientific dissemination through publications, conference presentations, reports, and other materials. As a final output, the study will also inform the development of a Good Practice Guide to promote HIV prevention and early diagnosis among migrant MSM, trans and non-binary people.

Studietype

Observasjonsmessig

Registrering (Antatt)

600

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Barcelona, Spania, 08015
        • Rekruttering
        • BCN Checkpoint

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

The study population consists of migrant men who have sex with men, trans people, and non-binary people aged 18 years or older who were born outside Spain and currently live in Catalonia. Participants will be recruited through BCN Checkpoint and through community-based and health-related channels, including printed and digital study materials distributed in community organisations, venues, social media, and collaborating services.

Beskrivelse

Inclusion Criteria:

  • Aged 18 years or older.
  • Self-identifies as MSM, ar a trans/non-binary person.
  • Born outside Spain and currently living in Catalonia.
  • Able and willing to provide written informed consent.
  • Able to communicate in one of the study languages.

Exclusion Criteria:

  • Not meeting one or more of the inclusion criteria.
  • Individuals who, at the time participation may be proposed, are considered by the study staff to have significantly impaired judgement, orientation, or understanding due to substance use or other circumstances, such as acute intoxication or severe physical or psychological distress requiring urgent medical or psychiatric care.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: ECOLOGIC_OR_COMMUNITY
  • Tidsperspektiver: CROSS_SECTIONAL

Kohorter og intervensjoner

Gruppe / Kohort
Migrant MSM, trans and non-binary people

Migrant men who have sex with men, trans people, and non-binary people participating in a community-based observational study on barriers to HIV prevention, early diagnosis, and access to sexual health services. Participants complete an anonymous survey and may optionally take part in an individual interview. Community-based interventions proposed by participants will later be selected, implemented, evaluated, and reimplemented if successful, with the aim of increasing first-time access to BCN Checkpoint for HIV testing and other sexual health services.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Perceived barriers to HIV testing and sexual health service access
Tidsramme: At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment

Participant-reported barriers to HIV testing, HIV prevention, and access to sexual health services, collected through the anonymous survey and optional qualitative interviews.

At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment
Community proposals for improving access to HIV prevention and early diagnosis
Tidsramme: At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment

Participant-reported proposals for improving access to HIV testing, HIV prevention, and sexual health services among migrant MSM, trans and non-binary people, collected through the anonymous survey and optional qualitative interviews.

At enrollment (survey) and during subsequent qualitative interviews, up to 8 months after enrollment

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Number of first-time migrant MSM, trans and non-binary users accessing BCN Checkpoint
Tidsramme: Assessed at the end of the second project year

Number of migrant men who have sex with men, trans people, and non-binary people who access BCN Checkpoint for the first time for HIV testing or other sexual health services during the intervention period. This indicator will be analysed using aggregated BCN Checkpoint service data and compared with a historical monthly baseline from previous years.

Assessed at the end of the second project year
Number of new HIV diagnoses among migrant MSM, trans and non-binary people
Tidsramme: Assessed at the end of the second project year

Number of new HIV diagnoses identified at BCN Checkpoint among migrant MSM, trans and non-binary people during the intervention and reimplementation period, using aggregated service indicators.

Assessed at the end of the second project year
Sources of first-time access to BCN Checkpoint
Tidsramme: Assessed at the end of the second project year

Self-reported source through which first-time users learned about BCN Checkpoint, collected to estimate which community-based interventions contributed most to new first-time visits.

Assessed at the end of the second project year

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

18. mai 2026

Primær fullføring (Antatt)

1. desember 2026

Studiet fullført (Antatt)

1. desember 2026

Datoer for studieregistrering

Først innsendt

4. juni 2026

Først innsendt som oppfylte QC-kriteriene

9. november 2026

Først lagt ut (Faktiske)

16. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared because the study collects sensitive information on migration history, sexual orientation and/or gender identity, HIV status, sexual health, stigma, and access to care. Results will be reported only in aggregate and anonymised form to minimise any risk of participant re-identification.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere